ArticleClinical and molecular hepatology2026

Extending MET-TRIB3 axis research in hepatocellular carcinoma: Immune contexture and patient subgroups: Letter to the editor on "MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation".

Lei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.